Literature DB >> 7707546

Theiler's virus as a vector for foreign gene delivery.

L Zhang1, S Sato, J I Kim, R P Roos.   

Abstract

DA strain and other strains of the TO subgroup of Theiler's murine encephalomyelitis viruses are members of the Cardiovirus genus of picornaviruses and produce a persistent demyelinating disease in mice. A recent study from our laboratory (W.-P. Kong, G. D. Ghadge, and R. P. Roos, Proc. Natl. Acad. Sci. USA 91:1796-1800, 1994) demonstrated that the leader, which is encoded at the N terminus of the Theiler's murine encephalomyelitis virus polyprotein, can be partially replaced by foreign sequences as well as completely deleted, with no loss of infectivity in BHK-21 cells. In this study, we have inserted up to 724 nucleotides into the leader coding region of an infectious DA clone. Recombinant viruses were produced, and the inserts were shown to be stable for at least three passages in BHK-21 cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7707546      PMCID: PMC189020     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Polyprotein processing of Theiler's murine encephalomyelitis virus.

Authors:  R P Roos; W P Kong; B L Semler
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

2.  Antigen chimaeras of poliovirus as potential new vaccines.

Authors:  K L Burke; G Dunn; M Ferguson; P D Minor; J W Almond
Journal:  Nature       Date:  1988-03-03       Impact factor: 49.962

3.  Monoclonal antibody defines determinant between Theiler's virus and lipid-like structures.

Authors:  R S Fujinami; A Zurbriggen; H C Powell
Journal:  J Neuroimmunol       Date:  1988-11       Impact factor: 3.478

4.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor.

Authors:  J Kang; H G Lemaire; A Unterbeck; J M Salbaum; C L Masters; K H Grzeschik; G Multhaup; K Beyreuther; B Müller-Hill
Journal:  Nature       Date:  1987 Feb 19-25       Impact factor: 49.962

5.  An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies.

Authors:  D J Evans; J McKeating; J M Meredith; K L Burke; K Katrak; A John; M Ferguson; P D Minor; R A Weiss; J W Almond
Journal:  Nature       Date:  1989-06-01       Impact factor: 49.962

6.  Attenuated Mengo virus as a vector for immunogenic human immunodeficiency virus type 1 glycoprotein 120.

Authors:  R Altmeyer; N Escriou; M Girard; A Palmenberg; S van der Werf
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

7.  Poliovirus type 1/type 3 antigenic hybrid virus constructed in vitro elicits type 1 and type 3 neutralizing antibodies in rabbits and monkeys.

Authors:  M G Murray; R J Kuhn; M Arita; N Kawamura; A Nomoto; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

8.  Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site I.

Authors:  M G Murray; J Bradley; X F Yang; E Wimmer; E G Moss; V R Racaniello
Journal:  Science       Date:  1988-07-08       Impact factor: 47.728

9.  Poliovirus RNA synthesis in vitro: structural elements and antibody inhibition.

Authors:  B L Semler; R Hanecak; L F Dorner; C W Anderson; E Wimmer
Journal:  Virology       Date:  1983-04-30       Impact factor: 3.616

10.  Engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimaeric virus which is neurovirulent for mice.

Authors:  A Martin; C Wychowski; T Couderc; R Crainic; J Hogle; M Girard
Journal:  EMBO J       Date:  1988-09       Impact factor: 11.598

View more
  6 in total

1.  Characterization of replication-competent hepatitis A virus constructs containing insertions at the N terminus of the polyprotein.

Authors:  Y Zhang; G G Kaplan
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

2.  A protein critical for a Theiler's virus-induced immune system-mediated demyelinating disease has a cell type-specific antiapoptotic effect and a key role in virus persistence.

Authors:  G D Ghadge; L Ma; S Sato; J Kim; R P Roos
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

3.  The epitope integration site for vaccine antigens determines virus control while maintaining efficacy in an engineered cancer vaccine.

Authors:  Kevin D Pavelko; Michael P Bell; Lavakumar Karyampudi; Michael J Hansen; Kathleen S Allen; Keith L Knutson; Larry R Pease
Journal:  Mol Ther       Date:  2013-04-09       Impact factor: 11.454

4.  Recombinant Encephalomyocarditis Viruses Elicit Neutralizing Antibodies against PRRSV and CSFV in Mice.

Authors:  Shu Zhu; Xin Guo; Lisa R Keyes; Hanchun Yang; Xinna Ge
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

5.  Expression and stability of foreign epitopes introduced into 3A nonstructural protein of foot-and-mouth disease virus.

Authors:  Pinghua Li; Xingwen Bai; Yimei Cao; Chenghao Han; Zengjun Lu; Pu Sun; Hong Yin; Zaixin Liu
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

6.  Effects of Keratinocyte-Derived Cytokine (CXCL-1) on the Development of Theiler's Virus-Induced Demyelinating Disease.

Authors:  Min H Kang; Young H Jin; Byung S Kim
Journal:  Front Cell Infect Microbiol       Date:  2018-01-23       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.